Robert Hugin
Patrimonio netto: 7 M $ in data 31/05/2026
Patrimonio netto: 7 M $ in data 31/05/2026
Il signor Robert J. Hugin è un amministratore indipendente di Biohaven Pharmaceutical Holding Co. Ltd. e un direttore indipendente presso Chubb Ltd. Fa parte del consiglio di amministrazione di Biohaven Pharmaceutical Holding Co. Ltd., Chubb Ltd., Choose New Jersey, Nereid Therapeutics, Inc., Darden School Foundation, Family Promise, Princeton University e University of Virginia Darden School of Business. Il signor Hugin è stato precedentemente impiegato come amministratore indipendente da Allergan Ltd. (Irlanda), come amministratore indipendente da Allergan Ltd. (Irlanda), come amministratore indipendente da Allergan Ltd. (Irlanda). (Irlanda), amministratore indipendente di Danaher Corp., presidente di Pharmaceutical Research & Manufacturers of America, presidente esecutivo di Celgene Ltd., amministratore indipendente di The Medicines Co. (Old), un amministratore fiduciario di Atlantic Health System, Inc., un amministratore fiduciario di Chilton Memorial Hospital, un presidente di HealthCare Institute of New Jersey e un ufficiale di fanteria di United States Marine Corps. È stato anche membro del consiglio di amministrazione di Coley Pharmaceutical Group, Inc. e ImClone LLC. Si è laureato alla Princeton University e ha conseguito un MBA alla University of Virginia Darden School of Business.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
CHUBB LIMITED 0,01% | 21/05/2026 | 21.961 ( 0,01% ) | 7 M $ | 31/05/2026 |
BIOHAVEN LTD. 0,01% | 28/04/2026 | 12.959 ( 0,01% ) | 142 679 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| CHUBB LIMITED | Direttore/Membro del Consiglio | 20/05/2020 |
| BIOHAVEN LTD. | Direttore/Membro del Consiglio | 28/09/2022 |
Princeton University
Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Direttore/Membro del Consiglio | - |
The Parker Institute For Cancer Immunotherapy
The Parker Institute For Cancer Immunotherapy Miscellaneous Commercial ServicesCommercial Services Operates cancer research | Direttore/Membro del Consiglio | - |
The Garden State Initiative | Presidente | - |
Nereid Therapeutics, Inc.
Nereid Therapeutics, Inc. BiotechnologyHealth Technology Operates as a bio-molecular condensate drug discovery and development company | Direttore/Membro del Consiglio | - |
University of Virginia Darden School of Business
University of Virginia Darden School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Direttore/Membro del Consiglio | - |
Darden School Foundation | Direttore/Membro del Consiglio | - |
Choose New Jersey
Choose New Jersey Miscellaneous Commercial ServicesCommercial Services Provides economic development services | Fondatore | - |
| ░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | - |
| Società | Posizione | Fine |
|---|---|---|
| ░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 24 |
|---|---|
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Danaher Corp.
Danaher Corp. Medical SpecialtiesHealth Technology Provides life sciences and diagnostic services | Health Technology |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology Develops novel therapeutic products and blood cell growth factors for the treatment of cancer | Health Technology |
The Medicines Co.
The Medicines Co. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops drugs for acute cardiovascular care | Health Technology |
Coley Pharmaceutical Group, Inc.
Coley Pharmaceutical Group, Inc. Pharmaceuticals: MajorHealth Technology Manufactures drugs to treat chronic diseases | Health Technology |
Atlantic Health System, Inc.
Atlantic Health System, Inc. Hospital/Nursing ManagementHealth Services Operates hospitals and medical health centers | Health Services |
J.P. Morgan & Co., Inc. (Old)
J.P. Morgan & Co., Inc. (Old) Regional BanksFinance Provides commercial banking and investment advisory services | Finance |
Princeton University
Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Chilton Memorial Hospital
Chilton Memorial Hospital Medical/Nursing ServicesHealth Services Operates hospitals and provides health care services | Health Services |
United States Marine Corps
United States Marine Corps SovereignGovernment Provides marine armed force services | Government |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Health Technology |
Family Promise
Family Promise Miscellaneous Commercial ServicesCommercial Services Operates as non-profit organization to help homeless and low-income families | Commercial Services |
Darden School Foundation | |
HealthCare Institute of New Jersey
HealthCare Institute of New Jersey The private company is based in Bridgewater, NJ. The HealthCare Institute of New Jersey (HINJ) is a trade association representing research-based biopharmaceutical and medical technology companies. It advocates for policies that expand patient access to medicines, medical devices, vaccines, and diagnostics, and promotes value-based healthcare and fair drug pricing. HINJ supports legislation on antimicrobial resistance and diagnostic regulation modernization, monitors policy to foster a competitive life sciences ecosystem, and emphasizes corporate social responsibility, including philanthropy, community engagement, environmental sustainability, and employee volunteerism. The organization advances diversity, equity, and inclusion initiatives, collaborates with government, academia, and industry partners, and administers patient assistance programs such as the Rx4NJ partnership and promotes awareness of NJSAVE. Christine Buteas has been the CEO of the company since 2024. | |
Allergan Ltd. (Ireland)
Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes pharmaceuticals, devices, biological, surgical & regenerative medicine products | Health Technology |
Choose New Jersey
Choose New Jersey Miscellaneous Commercial ServicesCommercial Services Provides economic development services | Commercial Services |
University of Virginia Darden School of Business
University of Virginia Darden School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biohaven Pharmaceutical Holding Co. Ltd.
Biohaven Pharmaceutical Holding Co. Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs to treat neurological and neuropsychiatric diseases | Health Technology |
Chubb Ltd.
Chubb Ltd. Property/Casualty InsuranceFinance Operates as a holding company for a family of property and casualty insurance companies | Finance |
Celgene Ltd.
Celgene Ltd. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company | Health Technology |
The Parker Institute For Cancer Immunotherapy
The Parker Institute For Cancer Immunotherapy Miscellaneous Commercial ServicesCommercial Services Operates cancer research | Commercial Services |
Nereid Therapeutics, Inc.
Nereid Therapeutics, Inc. BiotechnologyHealth Technology Operates as a bio-molecular condensate drug discovery and development company | Health Technology |
The Garden State Initiative | Commercial Services |
Biohaven Ltd.
Biohaven Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale